Opportunities for nano-formulations in type 2 diabetes mellitus treatments
MetadataShow full item record
Diabetes mellitus has been a threat to humans for many years. Amongst the different diabetes types, type 2 diabetes mellitus is the most common, and this is due to drastic changes in human lifestyle such as lack of exercise, stressful life and so on. There are a large number of conventional treatment methods available for type 2 diabetes mellitus. However, most of these methods are curative and are only applicable when the patient is highly symptomatic. Effective treatment strategies should be geared towards interfering with cellular and bio molecular mechanisms associated with the development and sustenance of the disease. In recent years, research into the medical potential of nanoparticles has been a major endeavor within the pharmaceutical industries. Nanoparticles display unique and tuneable biophysical characteristics which are determined by their shape and size. Nanoparticles have been used to manifest the properties of drugs, and as carriers for drug and vaccine delivery. Notwithstanding, there are further opportunities for nanoparticles to augment the treatment of a wide range of life threatening diseases that are yet to be explored. This review article seeks to highlight the application of potential nano-formulations in the treatment of type 2 diabetes mellitus. In addition, the activity of nanomedicine supplements in reversing insulin resistance is also discussed.
Showing items related by title, author, creator and subject.
Clifford, Rhonda (2004)People with diabetes mellitus are more likely to die from cardiovascular causes than those without diabetes, and modifiable risk factors, such as hyperglycaemia, dyslipidaemia and hypertension can be targeted in intervention ...
The Experience of Hypoglycaemia and Strategies Used for Its Management by Community-Dwelling Adults with Diabetes Mellitus: A Systematic ReviewTan, S.; Chen, H.; Taylor, B.; Hegney, Desley (2011)Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to influence therapy adherence and the quality of life of people with diabetes mellitus. No systematic reviews on the experience ...
The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetesBarnett, N.; Geelhoed, E.; Davis, E.; Jones, T.; De Bock, M.; Smith, G.; Norman, Richard (2016)Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard ...